Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million in funding, according to several sources with direct knowledge of the matter.

Graduates are prepared to pursue post-graduate, research-based degrees (M.S. and/or Ph.D.) in animal biosciences. The curriculum includes an animal science core (anatomy, nutrition, physiology, health ...

High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts WARN notice comes a day after ...

With leading researchers from seven institutions, the Quantitative & Computational Biosciences Graduate Program brings together the resources of the Texas Medical Center -- the world's largest complex ...

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space ...

Ensysce Biosciences Receives $14 Million NIH Grant for Clinical Development of Novel Opioid with Overdose Protection ACCESSWIRE · Ensysce Biosciences, Inc. Ensysce Biosciences, Inc.

The Analytical Biosciences Group (ABG) is one of the many Interest Groups within the Royal Society of Chemistry, bringing together members with an interest in the use of analytical chemistry ...

We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...

In trading on Wednesday, shares of Neurocrine Biosciences, Inc. (Symbol: NBIX) entered into oversold territory, hitting an RSI reading of 24.6, after changing hands as low as $119.76 per share.

Students are accepted from a wide range of backgrounds. Each application is considered individually. Typical contextual A-level offer This course does not participate in the contextual offer scheme.

SAN DIEGO--(BUSINESS WIRE)--Moonwalk Biosciences, an epigenetic biology and AI company, announced today the appointment of John Liles, Ph.D., as VP Biology and Translational Science, and the ...